Royal Bank of Canada’s HI-TECH PHARMACAL INC HITK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-6,362
Closed -$276K 6439
2014
Q1
$276K Buy
6,362
+300
+5% +$13K ﹤0.01% 3828
2013
Q4
$263K Buy
+6,062
New +$262K ﹤0.01% 3947

Royal Bank of Canada's HITK Position: Q2 2014 in Review

Royal Bank of Canada sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 6,362 shares — an estimated $276K sold.

Royal Bank of Canada first reported a position in HITK in Q4 2013 and held it in 2 quarters. The position peaked at $276K in Q1 2014. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • Royal Bank of Canada reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • Royal Bank of Canada sold 6,362 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $276K.
  • Royal Bank of Canada first reported a position in HI-TECH PHARMACAL INC in Q4 2013 and held it in 2 quarters.
  • Royal Bank of Canada's HI-TECH PHARMACAL INC position peaked at $276K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Royal Bank of Canada's 13F filing for Q2 2014, filed 14 Aug 2014.